Number of Shares
4.77 Mil
Current Holdings Value*
₹63.69 Mil
% of Portfolio
1.62%
Total Estimate Gain
₹3.44 Bil
% of Total Estimate Gain
28.76%

RBC Emerging Markets Equity Fund's Dr Reddy's Laboratories Ltd Holding Summary

As of 2025-03-31, RBC FUNDS TRUST held 4.77 Mil shares of Dr Reddy's Laboratories Ltd(NSE:DRREDDY), totaling ₹63.69 Mil. This investment constitutes 1.62% of their stock portfolio, and RBC FUNDS TRUST now holds 0.57% of the outstanding Dr Reddy's Laboratories Ltd(NSE:DRREDDY) stock.

The initial trade took place in 2019Q3. And since then RBC Emerging Markets Equity Fund has made 13 purchases of NSE:DRREDDY, at an average price of ₹976.28, for a total of 12.24 Mil shares. In addition, there have been 6 sales at an average price of ₹1,215.93 for 7.47 Mil shares. Based on historical transaction data and NSE:DRREDDY's current price of ₹1321.50, RBC Emerging Markets Equity Fund's estimated gain on his NSE:DRREDDY holdings is ₹3.44 Bil, reflecting a 28.76% gain to date.

RBC Emerging Markets Equity Fund NSE:DRREDDY (₹1321.50) Holding Chart

RBC Emerging Markets Equity Fund NSE:DRREDDY (₹1321.50) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price ₹-/Share
Shares Sold 0 Average Price ₹-/Share
Current Price ₹0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1